The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2016 | Renal complications in multiple myeloma – characteristics and treatment
Nelson Leung, MD from the Mayo Clinic, Rochester, MN gives an overview of the common kidney problems in multiple myeloma (MM). The proteins produced by the myeloma cells are toxic to the kidney in various ways. Prof. Leung discuses light chain cast nephropathy (LCCN), which is the most common complication and is a myeloma defining event, as well as immunoglobulin light chain (AL) amyloidosis, monoclonal immunoglobulin deposition disease (MIDD) and light chain proximal tubulopathy (LCPT) with or without Fanconi syndrome.
Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
